Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Acute Vasoreactivity Test Using INOflow Inhaled Nitric Oxide in Pulmonary Hypertension
jRCTs031220640Recruiting
- Start
- Apr 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nitric oxide in pulmonary hypertension (PH). Primary endpoint: Incidence of major adverse events. Started Apr 2023; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on jRCTs031220640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220640.